MEASuRE: Metreleptin Effectiveness And Safety Registry

Recruiting now

Conditions studied: Generalised Lipodystrophy, Partial Lipodystrophy

In brief

The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in the US and EEA.

Key facts

Study ID

NCT02325674

Run by

Chiesi Farmaceutici S.p.A.

People needed

100

Starts

2016-10-11

Expected to finish

2031-10-31

Last updated by the study team

2026-07-16

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients treated with metreleptin through commercial supply at the time or before enrolment into registry
• Patients who provide a written consent
• Patient coming off metreleptin clinical studies and continuing or restarting treatment with metreleptin through commercial supply

You may not qualify if…

• Patients currently treated with an investigational agent as part of a clinical trial

Where it is running

• Addenbrooke's Hospital — Cambridge, Cambridge, United Kingdom (enrolling)
• Hôpital Saint-Antoine — Paris, Paris, France (enrolling)
• Universitaetsklinikum Ulm — Ulm, Baden-Wurttemberg, Germany (enrolling)
• Kinderkrankenhaus Auf der Bult — Hanover, Lower Saxony, Germany (enrolling)
• Universitaetsklinikum Muenster — Münster, North Rhine-Westphalia, Germany (enrolling)
• Universitaetsklinikum Leipzig AoeR — Leipzig, Saxony, Germany (enrolling)
• Alma Mater Studiorum - Università di Bologna — Bologna, Bologna, Italy (enrolling)
• Azienda Ospedaliero Universitaria Pisana (Presidio di Cisanello) — Pisa, Pisa, Italy (enrolling)
• Universita del Piemonte Orientale "Amedeo Avogadro" — Novara, Verceilli, Italy (enrolling)
• Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States (enrolling)
• University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas, United States (enrolling)
• Nih/Niddk/Deob — Bethesda, Maryland, United States (enrolling)
• University of Michigan — Ann Arbor, Michigan, United States (enrolling)
• Childrens Hospital of Michigan — Detroit, Michigan, United States (enrolling)
• Endocrinology Research Associates — Columbus, Ohio, United States (enrolling)
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)
• UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)
• Seattle Children's Hospital — Seattle, Washington, United States (enrolling)
• CHRU Hôpital Claude Huriez — Lille, Nord, France (enrolling)
• Hôpital Robert Debré — Paris, Paris, France, France (enrolling)
• City of Hope — Duarte, California, United States
• Atlanta Diabetes Associates — Atlanta, Georgia, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Richmond University Medical Centre — Staten Island, New York, United States
• Children's Hospital of New Orleans/LSU Health Sciences Center — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.